Company Active LTD

Company profile

Biostatus Ltd

UK company 03079239, incorporated on 12 July 1995.

Biostatus Ltd is a UK company with status Active founded in 1995 based in East Midlands.

Company number
03079239
Incorporated
12 Jul 1995
Companies House status
Active

Company identity

Founded / incorporated
12 July 1995

Company number 03079239

Verify at Companies House
Legal name
BIOSTATUS LTD
Company type
Private Limited Company
Region
East Midlands
Registered address
56A CHARNWOOD ROAD
SHEPSHED
LEICESTERSHIRE
UNITED KINGDOM
LE12 9NP
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

Biostatus Ltd
No active corporate controller recorded.

Latest accounts

Financial period: 1 Dec 2023 to 30 Nov 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
7

Company events

Reference milestones and recent Companies House filing stream events.

6 events
26 Jul
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Aug
2026

Accounts due

Accounts Due

Next accounts due date

16 Jul
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUzMzEyNjA0MWFkaXF6a2N4

Published 16 Jul 2026 08:49

12 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Nov
2024

Accounts filed

Accounts

Last accounts made up date

12 Jul
1995

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2020
Funded years
2020
Age at first award
24 years

Projects

2020 Feasibility Studies Lead participant

Novel Cellular Probe Technologies for Screening Anti-Viral Therapeutic Candidates on Multiple Platforms

1 Jun 2020 to 28 Feb 2021

Awarded
£74,647
Total cost £74,647

COVID-19 has demonstrated that emerging viruses present acute threats to human health. During rapidly spreading epidemics, affected individuals need to be treated urgently with antivirals and agents that intercept tissue damage. The epidemic has highlighted the need for rapid and effective screening of both novel and repurposed agents so that promising th...

Product types

Feasibility Studies